Study on the Policies and Measures to Control Drug Distribution in Pharmacies by Bookkeeping
Article Sidebar
Main Article Content
Abstract
Objective: To study the development of drug law, policies and measures for controlling drug distribution with the requirement of bookkeeping. Method: This study was a documentary research collecting and reviewing relevant law, policies and measures in order to analyze the content and draw a conclusion using Gill Walk and Lucy Gilson’s policy triangle as a framework. Afterwards the researcher presented the conclusion to expert to ask for their suggestion. The expert in the study was the secretary and a member of working committee in drafting the Ministerial Rules on application for and licensing of selling modern medicines B.E. 2556, and a member of working committee in drafting ancillary law under the Ministerial Rules. Results: The requirement of bookkeeping in pharmacy originated in 1937. The Rules of Interior Ministry issued under Control of Drug Selling Act, B.E. 2479 mandated licensees of drug selling to have bookkeeping on selling of dangerous drugs and to record buyers’ names and addresses, drug names and amounts for each selling of dangerous drugs in the Book. Later on the requirement on recording names and surnames of buyers was derogated by the Ministerial Rules No. 2 issued under the Drug Act B.E. 2510. The law in effect once again requires the record of names and surnames of buyers in the Book for selling of particular dangerous drugs in order to fix the problem of drug abuse. Some expressed disagreement on the some items of dangerous drugs in the List with bookkeeping mandates, and also the requirement on recording names and surnames of buyers in the Book. Conclusion: In order for policy and measures for controlling drug distribution by pharmacy bookkeeping to be effective, stricter law enforcement is recommended. Evaluation of the impact of the policy and measures for controlling drug distribution by pharmacy bookkeeping is warrant.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Public Health Ministerial Rule in 2013 on license application and licensing of modern drug selling. Royal Gazette No. 130, Part 126A (Dec 27, 2013).
3. Drug Stores Club of Thailand and Thai Pharmacies Association. Letter to Food and Drug Adminis-tration on the list of dangerous drugs with the requirement on bookkeeping on July 27, 2015.
4. Matichon online. The Pharmacist urged for the revocation of the FDA rule on requesting names of medication buyers [online]. 2015 [cited Dec 21, 2015]. Available from: www.matichon.co.th/news_ de tail.php?newsid=1439737151
5. Walt G, Gilson L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan. 1994; 9: 353-70.
6. Thailand Encyclopedia for Youth from His Majesty's Royal Intention. Law and Thai society [online]. [cited 2015, Nov 10] Available from: kanchanapi sek.or.th/kp6/sub/book/book.php?book=18&chap=4&page=t18-4-infodetail01.html
7. Control of Drug Selling Act, B.E. 2479. Royal Gazette No. 54 (Apr 26, 1937)
8. Ministerial regulations of Ministry of Interior Issued under the Control of Drug Selling Act, B.E. 2479. Royal Gazette No. 54 (Sept 27, 1937).
9. Control of Drug Selling Act (No. 2), B.E. 2481. Royal Gazette No. 56 (May 1, 1939)
10. Ministerial regulations of Ministry of Interior Issued under the Control of Drug Selling Act, B.E. 2479 as amended by the Control of Drug Selling Act (No. 2) B.E. 2481. Royal Gazette No. 56 (Dec 11, 1939)
11. Drug Selling Act B.E. 2493. Royal Gazette No. 71, Part 67 (Dec 26, 1950).
12. Public Health Ministerial Rule No. 2 (B.E. 2494) Issued under the Drug Selling Act B.E. 2493. Royal Gazette No. 68, Part 31A (May 15, 1951).
13. Public Health Ministerial Rule No. 3 (B.E. 2494) Issued under the Drug Selling Act B.E. 2493. Royal Gazette No. 68, Part 31A (May 15, 1951).
14. Drug Act, B.E. 2510. Royal Gazette No. 84, Part101 special (Oct 20, 1967).
15. Public Health Ministerial Rule No. 2 (B.E. 2510) Issued under the Drug Act B.E. 2510. Royal Gazette No. 84, Part 123A Special (Dec 15, 1967).
16. Public Health Ministerial Rule No. 15 (B.E. 2525) Issued under the Drug Act B.E. 2510. Royal Gazette No. 99, Part 164A Special (Nov 3, 1982).
17. Announcement of the Food and Drug Adminis- tration on the specification of the forms for application and license to sell modern medicines. Royal Gazette No. 131, Part 172D (Sept 5, 2014).
18. Announcement of the Food and Drug Adminis- tration on list of dangerous drugs with the requirement of selling record. Royal Gazette No. 132, Part 179D (Aug 4, 2014).
19. Bureau of Drug, Food and Drug Administration. Statistics on drug business license in Thailand in 2014. [online]. 2015 [cited 2015, Dec 21] Available from: drug.fda.moph.go.th/zone_search/files/sea 001_d19.asp.
20. Bureau of Drug, Food and Drug Administration. Document on the designation of authority among units within Bureau of Drug. Nonthaburi, Ministry of Public Health; 2015.
21. Division of Consumer Empowerment, Food and Drug Administration. Statistics of the amount of fines on the violation of the Drug Act. Nonthaburi, Ministry of Public Health; 2015.
22. Narcotics Control Division, Food and Drug Administration. Changing legal status of pseudo- ephedrine to schedule II psychotropic drug [online]. 2012 [cited 2015, Dec
21] Available from: narcotic.fda.moph.go.th/welcome/?p=2720.
23. Food and Drug Administration. Report on the fact: case of the measures to control 3 formulas of combined drugs for cold in the form of tablets/capsules containing pseudoephedrine [online]. 2012 [cited 2015, Dec 21] Available from: wwwapp1.fda.moph.go.th/drug/zone_service/files/Factsheet%20FINAL.pdf.
24. Sermsinsiri W. Presentation in Food and Drug Administration meeting: the approaches to strengthen the measure to control the distribution of drugs with high risk for abuses. Nonthaburi, Ministry of Public Health; 2015.
25. Food and Drug Administration. Minutes of the working group for drafting the law on methods and requirement on licensing of drug selling and renewal of license for drug selling. Nonthaburi, Ministry of Public Health; 2006.
26. Food and Drug Administration. About us [online]. 2015 [cited Dec 21, 2015]. Available from: www.fda.moph.go.th/2015/viewData.php?ID_Wsc_Fda_Data=5.
27. Community Pharmacy Association. Vision and mission [online]. 2015 [cited Dec 21, 2015]. Available from: www.pharcpa.com/vision.html
28. Pharmacy Council. History [online]. 2015. [cited Dec 21, 2015]. Available from: www.pharmacy council .org/index.php?option=content&menuid=31
29. Foundation for Consumer. About us [online]. 2015 [cited Dec 21, 2015]. Available from: www.con sumerthai.org/2015/index.php/contact/history.html
30. ASTV Manager online. FDA insisted on requesting names of buyers of anti-cough drugs to deter the use as narcotics, without jeopardize consumer right and urging for 3-6 months to evaluate the measure [online]. 2015 [cited Aug 20, 2015]. Available from: www.manager.co.th/QOL/ ViewNews.aspx?NewsID=9580000094549
31. Thai Pharmacies Association. Letter to Food and Drug Administration on opinions and the urge to enforce preventive measure for drug abuse on Sept 5, 2015.
32. Khaosod. Pharmacist group urged Pharmacy Council coming forward to ask FDA to amend the Announcement that strictly controls pediatric syrups for cold by requesting names of buyers. [online]. 2015 [cited Oct 21, 2015]. Available from: www.khaosod.co.th/view_newsonline.php?newsid=1439797906
